Priya Weerasinghe

1.2k total citations
18 papers, 934 citations indexed

About

Priya Weerasinghe is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Priya Weerasinghe has authored 18 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Priya Weerasinghe's work include Berberine and alkaloids research (6 papers), Cell death mechanisms and regulation (6 papers) and Synthesis and bioactivity of alkaloids (3 papers). Priya Weerasinghe is often cited by papers focused on Berberine and alkaloids research (6 papers), Cell death mechanisms and regulation (6 papers) and Synthesis and bioactivity of alkaloids (3 papers). Priya Weerasinghe collaborates with scholars based in United States and Canada. Priya Weerasinghe's co-authors include L. Maximilian Buja, Andrejs Liepins, Shou-Ching Tang, Haruyo Ichikawa, Manoj K. Pandey, Indra D. Bhatt, Shishir Shishodia, Muraleedharan G. Nair, Gautam Sethi and Bharat B. Aggarwal and has published in prestigious journals such as Biochemical Pharmacology, Molecular Therapy and The Prostate.

In The Last Decade

Priya Weerasinghe

17 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priya Weerasinghe United States 14 536 227 202 133 105 18 934
Hye‐Sook Seo South Korea 18 532 1.0× 201 0.9× 177 0.9× 122 0.9× 90 0.9× 27 936
Alpna Tyagi United States 22 783 1.5× 281 1.2× 235 1.2× 121 0.9× 114 1.1× 31 1.4k
Hong Xiang Zuo China 21 582 1.1× 157 0.7× 196 1.0× 214 1.6× 102 1.0× 37 1.3k
Ke-Wang Luo China 17 397 0.7× 204 0.9× 199 1.0× 113 0.8× 149 1.4× 29 918
Lalitha Ramachandran Singapore 8 557 1.0× 121 0.5× 197 1.0× 203 1.5× 87 0.8× 11 1.0k
An-Cheng Huang Taiwan 17 557 1.0× 128 0.6× 131 0.6× 128 1.0× 75 0.7× 20 901
Jizu Yi United States 20 838 1.6× 218 1.0× 157 0.8× 104 0.8× 62 0.6× 35 1.5k
Anna L. Greenshields Canada 16 550 1.0× 118 0.5× 159 0.8× 162 1.2× 64 0.6× 41 1.2k
Sung‐Moo Kim South Korea 20 525 1.0× 122 0.5× 205 1.0× 118 0.9× 81 0.8× 33 1.2k
T C Hsieh United States 13 479 0.9× 127 0.6× 109 0.5× 88 0.7× 93 0.9× 16 848

Countries citing papers authored by Priya Weerasinghe

Since Specialization
Citations

This map shows the geographic impact of Priya Weerasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priya Weerasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priya Weerasinghe more than expected).

Fields of papers citing papers by Priya Weerasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priya Weerasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priya Weerasinghe. The network helps show where Priya Weerasinghe may publish in the future.

Co-authorship network of co-authors of Priya Weerasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of Priya Weerasinghe. A scholar is included among the top collaborators of Priya Weerasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priya Weerasinghe. Priya Weerasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Roberts, Nathan B., Robert Brown, L. Maximilian Buja, & Priya Weerasinghe. (2020). Molecular Mechanisms of Curcumin in COVID-19 Treatment and Prevention: A Global Health Perspective. Medical Research Archives. 8(10). 8 indexed citations
3.
Brown, Robert, Kristine E. Konopka, Priya Weerasinghe, et al.. (2017). Morphoproteomics Identifies SIRT1 and EZH2 Pathways as Commonalities in B-cell Acute Lymphoblastic Leukemia: Pathogenetic Implications and Opportunities for Therapeutic Intervention.. PubMed. 47(1). 3–9. 3 indexed citations
4.
Rogers, John, et al.. (2017). Morphoproteomic-Guided Treatment of Chemotherapy Resistant Colon Cancer using Natural Based Therapies: A Case Study.. PubMed. 47(2). 217–220.
5.
Weerasinghe, Priya & L. Maximilian Buja. (2012). Oncosis: An important non-apoptotic mode of cell death. Experimental and Molecular Pathology. 93(3). 302–308. 180 indexed citations
6.
Weerasinghe, Priya, et al.. (2012). A model for cardiomyocyte cell death: Insights into mechanisms of oncosis. Experimental and Molecular Pathology. 94(1). 289–300. 25 indexed citations
7.
Chai, Hong, et al.. (2010). Sorafenib downregulates ERK/Akt and STAT3 survival pathways and induces apoptosis in a human neuroblastoma cell line.. PubMed. 3(4). 408–15. 38 indexed citations
8.
Guan, Yongli, Yifei Li, KangAe Lee, et al.. (2009). G-rich Oligonucleotides Inhibit HIF-1α and HIF-2α and Block Tumor Growth. Molecular Therapy. 18(1). 188–197. 21 indexed citations
9.
Buja, L. Maximilian & Priya Weerasinghe. (2008). Unresolved issues in myocardial reperfusion injury. Cardiovascular Pathology. 19(1). 29–35. 47 indexed citations
10.
Weerasinghe, Priya, Yifei Li, Yongli Guan, et al.. (2008). T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signaling. The Prostate. 68(13). 1430–1442. 26 indexed citations
11.
Tang, Shou-Ching, et al.. (2007). Aurintricarboxylic Acid Inhibits Protein Synthesis Independent, Sanguinarine-Induced Apoptosis and Oncosis. Toxicologic Pathology. 35(2). 300–309. 20 indexed citations
12.
Weerasinghe, Priya, Gabriela García, Ping Yuan, et al.. (2007). Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. International Journal of Oncology. 31(1). 129–36. 83 indexed citations
13.
Aggarwal, Bharat B., Haruyo Ichikawa, Priya Weerasinghe, et al.. (2006). From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets. 10(1). 87–118. 221 indexed citations
14.
Weerasinghe, Priya, et al.. (2006). Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Experimental and Toxicologic Pathology. 58(1). 21–30. 38 indexed citations
15.
Ding, Zhihu, et al.. (2002). The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochemical Pharmacology. 63(8). 1415–1421. 90 indexed citations
16.
Weerasinghe, Priya, et al.. (2001). Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death. Cell Biology and Toxicology. 17(6). 371–381. 57 indexed citations
17.
Weerasinghe, Priya, et al.. (2001). Bax, Bcl-2, and NF-κB Expression in Sanguinarine Induced Bimodal Cell Death. Experimental and Molecular Pathology. 71(1). 89–98. 47 indexed citations
18.
Weerasinghe, Priya, et al.. (2001). Sanguinarine Induces Bimodal Cell Death in K562 but not in High Bcl-2-expressing JM1 Cells. Pathology - Research and Practice. 197(11). 717–726. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hye‐Sook Seo Breakdown of academic impact, for papers by Alpna Tyagi Breakdown of academic impact, for papers by Hong Xiang Zuo Breakdown of academic impact, for papers by Ke-Wang Luo Breakdown of academic impact, for papers by Lalitha Ramachandran Breakdown of academic impact, for papers by An-Cheng Huang Breakdown of academic impact, for papers by Jizu Yi Breakdown of academic impact, for papers by Anna L. Greenshields Breakdown of academic impact, for papers by Sung‐Moo Kim Breakdown of academic impact, for papers by T C Hsieh
Rankless by CCL
2026